Mycoplasma arthritidis-derived mitogen (MAM), a bacterial superantigen, has been crystallized in complex with its human receptor, major histocompatibility complex (MHC) class II antigen, by the hanging-drop vapor-diffusion method. Crystals were obtained under three conditions, with ammonium sulfate, phosphate salt and PEG 8000 as the precipitant. The crystals grown under these conditions all belong to space group I222, with the same unit-cell parameters: a = 137.4, b = 178.2, c = 179.6 A Ê . Diffraction data were collected to 3.3 and 3.4 A Ê resolution from crystals of native and selenomethionylated MAM±MHC complexes, respectively. Self-and cross-rotation function calculations suggest the presence of two complex molecules in the asymmetric unit, resulting in a V M of 4.0 and a solvent content of 69%. An interpretable electron-density map was produced using a combination of molecular replacement and SAD phasing.
Introduction
Superantigens (SAgs) are functionally related immunoregulatory proteins generally produced by bacteria and viruses (Kappler et al., 1988; Kotzin et al., 1993; Li et al., 1999; White et al., 1989) . By simultaneously binding to the T-cell antigen receptor (TCR) on T cells and to the major histocompatibility complex (MHC) antigen on antigen-presenting cells, SAgs can stimulate the activation of a large fraction (up to 20%) of T cells bearing particular TCR V elements. In contrast, conventional peptide antigens can trigger T-cell activation only at the level of one per 10 5 cells. The recognition of SAgs by T cells may have several consequences for the responding T cells, including proliferation and expansion, the induction of nonresponsiveness (anergy) or even cell death (deletion) (MacDonald et al., 1993) . Owing to their unique features and biological effects, SAgs have been hypothesized to play important roles in a number of human diseases, including food poisoning, toxic shock syndrome and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis (RA) (Abe et al., 1992; Conrad et al., 1994; Kotzin et al., 1993; McCormick et al., 2001; Renno & Acha-Orbea, 1996) .
The best-characterized group of SAgs belongs to the pyrogenic toxin SAg family from Staphylococcus aureus and Streptococcus pyogenes (Choi et al., 1990; Dellabona et al., 1990; . Some of these SAgs have been structurally characterized both in unbound forms and in complexes with the TCR and MHC molecules; the structures show apparent diversity in the inter-actions between SAgs and their immunoreceptors (Fraser et al., 2000; Li et al., 1999; Mitchell et al., 2000; Papageorgiou & Acharya, 2000; Sundberg et al., 2002; Swaminathan et al., 1992) . Among the superantigenic proteins of viral origin, only mouse mammary tumor virusencoded SAgs have been elucidated in detail (Acha-Orbea & MacDonald, 1995) . Other viral proteins have been reported to exhibit superantigenic activity (Li et al., 1999) , including proteins encoded by an endogenous human retrovirus reported recently (Stauffer et al., 2001; Sutkowski et al., 2001) .
Mycoplasma arthritidis-derived mitogen (MAM) is produced by M. arthritidis, a member of the eubacterial class Mollicutes (Cole, 1991) . MAM functions like a conventional SAg and can induce spontaneous chronic arthritis, which resembles human RA, in genetically susceptible strains of rodents (Cole & Atkin, 1991; Cole & Grif®ths, 1993) . Mature MAM is a basic thermostable and acidlabile protein of 213 amino acids (Cole et al., 1996) . Although the molecular weight of MAM is within the range of values seen for staphylococcal and streptococcal SAgs, the primary sequence of MAM does not exhibit signi®cant global homology to any other SAg. Although MAM, like other SAgs, interacts with TCRs in a V-restricted fashion, the binding of MAM to TCR is in¯uenced by the CDR3 region of the TCR (Hodtsev et al., 1998) . This is in contrast to other SAgs, suggesting that MAM represents a new type of ligand for TCRs distinct from both conventional peptide antigens and other known SAgs. Here, we report the crystallization and preliminary crystallographic analysis of MAM complexed with its crystallization papers human immunoreceptor, the class II MHC molecule, HLA-DR1, in the context of a haemagglutinin peptide (HA).
Material and methods

Expression and purification
Soluble MAM was overexpressed in Escherichia coli using the pGEX-6P-1 GST fusion protein expression system (Amersham Pharmacia) with a modi®ed protocol (Langlois et al., 2000) . Brie¯y, E. coli BL21(DE3) cells transformed with the plasmid pWM.25B (Langlois et al., 2000) were grown to an OD 600 of 0.8 at 310 K with shaking in superbroth medium containing 0.1 mg ml À1 ampicillin. The temperature was reduced to 303 K and isopropyl -d-1-thiogalactopyranoside (IPTG) was added to a ®nal concentration of 0.1 mM. After 5 h induction, cells were harvested by centrifugation and resuspended in 100 ml phosphate-buffered saline (PBS) per litre of culture. After sonication of the resuspended cells, the lysate was clari®ed by centrifugation. The supernatant was loaded onto a glutathione Sepharose 4B (Amersham Pharmacia) column and puri®ed according to the manufacturer's instructions. The puri®ed MAM-GST fusion protein was digested overnight at 277 K with PreScission protease (Amersham Pharmacia) at a ratio of 2 U per milligram of fusion protein by dialysis against a protease buffer containing 50 mM Tris±HCl pH 8.0, 100 mM NaCl, 1 mM EDTA and 1 mM DTT. The completeness of digestion was monitored by SDS± PAGE. MAM was separated from GST by passing twice through glutathione Sepharose 4B. The¯owthrough was concentrated and applied to a Waters Protein-Pak 300SW column using a Waters 625 HPLC system (Waters Corporation) for further puri®cation in a buffer containing 10 mM Tris±HCl pH 8.0, 100 mM NaCl and 1 mM DTT. The purity and molecular mass were veri®ed using electrospray mass spectrometry with a Finnigan-MAT TSQ-700 triple-quadrupole mass spectrometer equipped with an electrospray ionization source (San Jose, CA, USA) ( Figs. 1b and 1c) .
The HLA-DR1, loaded with a haemagglutinin peptide (HA) (PKYVKQNTLK-LAT), was prepared from individually expressed inclusion bodies of the DR1 and chains using a previously described refolding protocol (Frayser et al., 1999) . To prepare the selenomethioine-substituted (SeMet) derivative, the plasmid pLM1encoding the chain of HLA-DR1 was transformed into the methionine-auxo-trophic E. coli strain B834 (Novagen). Cells were grown in minimal medium containing SeMet at 310 K. Puri®cation of the inclusion body of the SeMet chain was performed using the same method as that for the native chain. Through use of the same protocol to produce the native protein, the puri®ed inclusion body of the SeMet chain was crystallization papers refolded together with the native DR1 chain in the presence of the HA peptide.
Crystallization
Puri®ed MAM was concentrated to 8.8 mg ml À1 using a Millipore stirred cell. Native and SeMet HLA-DR1±HA complexes were buffer-exchanged to 20 mM HEPES pH 7.5, 100 mM NaCl and 1 mM DTT and concentrated to 5.4 mg ml À1 . For crystallization, 50 ml of the HLA-DR1±HA complex was mixed with 17 ml MAM and 9 ml 9 mM Zn(OAc) 2 , resulting in an equimolar ratio of MAM and DR1. Prior to crystallization, the complex mixture was incubated for 30 min. Initial crystallization conditions were established using Hampton Research Crystal Screen I, a commercially available sparse-matrix screen. Crystals appeared in three conditions, Nos. 32, 35 and 36, in which sulfate, phosphate and PEG 8000 were used as the precipitant, respectively. These conditions were further optimized. Microseeding was used to produce large crystals of both the native and SeMet complexes. The best crystals were grown at room temperature in hanging drops by mixing 2 ml protein solution with an equal volume of reservoir solution containing 1.7 M potassium sodium phosphate and 0.1 M HEPES pH 7.5. After equilibration overnight, the drop was introduced with 0.5 ml of stock solution of crystal seeds produced by crushing small crystals and diluting to varying degrees in the crystallization buffer. New crystals of both native and SeMet complexes appeared within 3 d and continued to grow for 2±3 weeks.
Data collection
Prior to data collection, all crystals were transferred to a cryoprotectant solution (mother liquor supplemented with 20% glycerol) and¯ash-cooled in a nitrogen-gas stream. Native data were collected to 3.3 A Ê resolution at 100 K using a CCD detector at beamline 19-BM of the Advanced Photon Source (APS), Argonne National Laboratory, USA. A set of single-wavelength anomalous diffraction (SAD) data (! = 0.978 A Ê ) for the SeMet complex crystal was collected to 3.4 A Ê resolution at 100 K using a Brandeis-B4 CCD detector at beamline X12C of the National Synchrotron Light Source (NSLS), Brookhaven National Laboratory. All data were processed, scaled and reduced using the program HKL2000 (Otwinowski & Minor, 1997) and the CCP4 suite (Collaborative Computational Project, Number 4, 1994) .
Self-rotation functions
A self-rotation function was calculated for the SAD data with the program GLRF from the REPLACE suite of programs (Tong & Rossmann, 1990) . Data in the resolution range 20±4 A Ê were used, with an integration radius of 25 A Ê .
Molecular replacement and SAD phasing
With the crystal structure of the HLA-DR1±HA complex (Stern et al., 1994 ) as a search model, the cross-rotation function was calculated using the native data with the program AMoRe (Navaza, 1994) . Molecular replacement (MR) generated clear solutions for the HLA-DR1 molecules. Using the program SOLVE (Terwilliger & Berendzen, 1999) , we performed SAD phasing with the phase contribution from the DR1±HA complexes using the 3.4 A Ê SAD data. The positions for six Se atoms were clearly de®ned. With the combined MR and SAD phasing information, non-crystallographic symmetry (NCS) averaging using the program RESOLVE (Terwilliger, 2001) was able to produce an interpretable map.
Results and discussion
The MAM protein puri®ed through our protocol is very pure, as judged by the single monomeric peak seen in gel-®ltration chromatography and electrospray mass spectrometry (Figs. 1a and 1c) .
Bar-shaped crystals of the MAM±HA± DR1 complex were ®rst observed from condition Nos. 32 and 36 from Hampton Research Crystal Screen I with ammonium sulfate and PEG 8000 as the precipitant, respectively (Fig. 2b) . Wedge-like crystals appeared under the phosphate condition (No. 35) almost six months later (Fig. 2a) . The crystals obtained using the phosphate condition diffracted slightly better than those from the other two conditions. Therefore, the phosphate condition was further optimized. Even with microseeding, the majority of crystals appeared to be single when small but tended to cluster together when they grew larger. Using a hair-tool to remove small crystals attached to large crystals under a microscope, we were able to obtain single crystals with average dimensions of 0.15 Â 0.1 Â 0.1 mm. Although the crystals are still small, they diffracted to 3.3 and 3.4 A Ê resolution for the native and SeMet complex crystals, respectively, using synchrotron X-ray sources. Native and SAD diffraction data were then able to be collected (Table 1) .
Surprisingly, although the crystals obtained from the three conditions display different morphologies, they all belong to the same space group I222, with the same unit-cell parameters: a = 137.4, b = 178.2, c = 179.6 A Ê . Therefore, it is possible that each asymmetric unit of the crystal lattice contains two, three or four MAM±HA±DR1 complexes. The Matthews coef®cients (V M ) were accordingly calculated to be 4.0, 3.0 or 2.0 A Ê 3 Da À1 , respectively. 
crystallization papers
The self-rotation function shows a peak of 6.4' height with a signal-to-noise (S/N) ratio of 3.6 at the spherical polar coordinates (9 = 0, 2 = 45, = 180 ) ( Fig. 3) , indicating the presence of a twofold non-crystallographic symmetry (NCS) axis. This implies that either two or four complexes must be present in each asymmetric unit, resulting in solvent contents of 69 or 39%, respectively. Cross-rotational and translational function calculations further con®rmed there to be two MAM±HA±DR1 complex molecules in an asymmetric unit. At a resolution range 20±4 A Ê , two solutions for the HLA-DR1 molecules could be obtained with correlation coef®cients (CC) of 15.0 and 14.6%, respectively. The next highest noise peak showed a CC value of 11.2%. Using the solutions of the cross-rotation function, single-body translation-function calculation at 8±4 A Ê generated two solutions with CC values of about 21% for both solutions and of 10% for the highest noise peak. When one of the solutions was ®xed, translation-function calculation produced a solution for the second HA±DR1 molecule with the same crystallographic origin as the ®rst one, resulting in a dramatically increased CC value to 40% and an R factor decrease from 55 to 47%. The angular relationship between the two solutions was consistent with the result from the self-rotation function calculation.
The resultant electron-density maps showed some densities beyond the boundary of the DR1±HA molecules, but were insuf®cient to enable tracing of the MAM molecule. Combining the phase contribution from the MR solutions of the MHC molecules, we performed a phased SAD calcula-tion using the 3.4 A Ê SAD data with the program SOLVE (Terwilliger & Berendzen, 1999) . The positions for all six Se atoms were clearly de®ned. These positions were further veri®ed on the expected sites on the chain of the MHC molecules, which were independently determined using the molecularreplacement method. Although the SAD phasing only gave a ®gure-of-merit (FOM) of 0.09, the FOM of the combined MR and SAD phases was 0.62. With the combined MR and SAD phase information, noncrystallographic symmetry (NCS) averaging using the program RESOLVE (Terwilliger, 2001) was able to produce an interpretable map. Structure determination is currently in progress.
